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The autonomic nervous system controls heart rate and contractility through sympathetic
and parasympathetic inputs to the cardiac tissue, with acetylcholine (ACh) and noradren-
alin (NA) as the chemical transmitters. In recent years, it has become clear that speciﬁc
Regulators of G protein Signaling proteins (RGS proteins) suppress muscarinic sensitivity
and parasympathetic tone, identifying RGS proteins as intriguing potential therapeutic tar-
gets. In the present study, we have identiﬁed the effects of 1μMACh and 1μM NA on the
intrinsic action potentials of sinoatrial (SA) nodal and atrial myocytes. Single cells were enzy-
matically isolated from the SA node or from the left atrium of rabbit hearts. Action potentials
were recorded using the amphotericin-perforated patch-clamp technique in the absence
and presence of ACh, NA, or a combination of both. In SA nodal myocytes, ACh increased
cycle length and decreased diastolic depolarization rate, whereas NA decreased cycle
length and increased diastolic depolarization rate. Both ACh and NA increased maximum
upstroke velocity. Furthermore, ACh hyperpolarized the maximum diastolic potential. In
atrial myocytes stimulated at 2Hz, both ACh and NA hyperpolarized the maximum diastolic
potential, increased the action potential amplitude, and increased the maximum upstroke
velocity. Action potential duration at 50 and 90% repolarization was decreased by ACh,
but increased by NA.The effects of both ACh and NA on action potential duration showed
a dose dependence in the range of 1–1000 nM, while a clear-cut frequency dependence
in the range of 1–4Hz was absent. Intermediate results were obtained in the combined
presence of ACh and NA in both SA nodal and atrial myocytes. Our data uncover the extent
to which SA nodal and atrial action potentials are intrinsically dependent on ACh, NA, or a
combination of both and may thus guide further experiments with RGS proteins.
Keywords: cardiac myocytes, sinoatrial node, left atrium, patch-clamp, action potentials, pacemaker activity,
acetylcholine, noradrenalin
INTRODUCTION
Electrical activity of cardiac cells is modulated through adrener-
gic and muscarinic stimulation. The intrinsic pacemaker activity
of sinoatrial (SA) nodal cells is accelerated upon noradrenalin-
mediated stimulation of the adrenergic β-receptors and decel-
erated by acetylcholine-mediated stimulation of the muscarinic
M2-receptors. Both are G protein-coupled receptors (GPCRs).
In recent years, it has become widely appreciated that GPCR
signaling in SA nodal pacemaker cells is much more complex
than activation of a single membrane current, e.g., activation of
the acetylcholine-activated outward potassium current IK,ACh in
response to a release of acetylcholine (Maltsev and Lakatta, 2010;
van Borren et al., 2010). If noradrenalin binds to its β-receptor,
it activates adenylyl cyclases through its stimulatory G protein
α-subunit (Gαs) and thus increases cAMP and protein kinase A
levels. Similarly, if acetylcholine binds to its receptor, it decreases
these levels through its inhibitory G protein α-subunit (Gαi). In
addition, acetylcholine exerts its effects through a Gβγ-mediated
activation of the aforementioned IK,ACh. Noradrenalin acceler-
ates the interdependent “membrane clock” and “calcium clock” of
the pacemaker cell, whereas these are decelerated by acetylcholine
(Maltsev and Lakatta, 2010; van Borren et al., 2010).
It should be kept in mind that noradrenalin not only stimulates
the Gs-coupled β1–β3 adrenoceptors but also the Gq-coupled α1
and Gi-coupled α2 adrenoceptors, and that acetylcholine not only
stimulates the Gi-coupled M2-receptor but also the other mus-
carinic receptors, including the Gq-coupled M3-receptor, which is
functionally present in the murine sinoatrial node (Abramochkin
et al., 2012). Adding to this complexity, it has also become clear
that GPCR signaling is not a simple linear pathway of recep-
tor, G protein, and effector. Signaling may be modulated by G
protein-binding partners, speciﬁcally by members of the family of
Regulators of G protein Signaling proteins (RGS proteins). RGS
proteins may suppress muscarinic sensitivity and parasympathetic
tone and thus affect heart rate and susceptibility to atrial ﬁb-
rillation. If neuronally expressed, RGS proteins may also affect
both sympathetic and parasympathetic output in addition to their
direct effects in cardiac myocytes. The function of RGS proteins
and their potential as therapeutic targets have recently received
attention in several reviews (Sjögren and Neubig, 2010; Sjögren
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et al., 2010; Kimple et al., 2011; Tilley, 2011; Zhang and Mende,
2011).
Studies with transgenic mice have underlined the important
role of speciﬁc RGS proteins in the heart. In RGS4 knockout
(RGS4−/−) mice, Cifelli et al. (2008) observed enhanced heart
rate responses to the cholinergic agonist carbamylcholine chlo-
ride (carbachol), both in intact animals and in isolated hearts. In
line with these observations, the beating frequency of isolated SA
nodal myocytes, as assessed with the perforated patch-clamp tech-
nique at room temperature, did not differ between RGS4−/− and
control under basal conditions, but showed an enhanced suscep-
tibility to carbachol. This enhanced susceptibility was associated
with a reduced desensitization and a slower deactivation of IK,ACh
in RGS4−/− myocytes. Similar observations were made by Yang
et al. (2010) with RGS6 knockout (RGS6−/−) mice. An enhanced
bradycardia in response to carbachol was found in intact animals,
in perfused hearts, and in isolated SA nodal myocytes. Whole-cell
patch-clamp recordings from cultured RGS6−/− atrial myocytes
revealed a signiﬁcant reduction in the time course of activation
and deactivation of IK,ACh as well as the extent of its desensiti-
zation. Of note, perfused hearts from RGS6−/− mice showed a
normal chronotropic response to the β-adrenergic agonist iso-
proterenol. Posokhova et al. (2010) also studied heart rate and
IK,ACh in RGS6
−/− mice. In intact animals, they found a mild rest-
ing bradycardia and an enhanced bradycardic effect of carbachol.
In whole-cell patch-clamp recordings from adult SA nodal and
cultured neonatal atrial myocytes, IK,ACh showed a slowed deacti-
vation rate, which was also observed in case of deletion of the type
5 G protein β subunit (Gβ5), indicating that the effect is mediated
by the RGS6/Gβ5 complex rather than by RGS6 itself.
The modulatory role of endogenous RGS proteins in the mus-
carinic and adrenergic control of heart rate had already been
demonstrated in studies by Fu et al. (2006, 2007). Furthermore,
Bender et al. (2008) had shown that the β-adrenergic effects on
deactivation of IK,ACh, i.e., a marked increase in the time constant
of its deactivation, are mediated via RGS10 in rat atrial myocytes.
Also, Tuomi et al. (2009) had found that atrial effective refrac-
tory periods were smaller in RGS2 knockout mice, likely due to
enhancedmuscarinicM3-receptor activity, and that thesemice had
an enhanced susceptibility to pacing-induced atrial tachycardia
and ﬁbrillation.
Given the potential role of RGS proteins as therapeutic means
for modulating heart rate and atrial effective refractory period, it
is important to know the effects of noradrenalin and acetylcholine
on the intrinsic electrical activity of cardiac myocytes, speciﬁcally
SA nodal and atrial myocytes. Over a period of decades, studies
at the whole-heart and tissue levels have provided us with impor-
tant data regarding the effects of sympathetic and parasympathetic
stimulation and their interaction (e.g.,Toda andShimamoto,1968;
Grodner et al., 1970; Levy, 1971; Mackaay et al., 1980; Boyett
et al., 1995; Brack et al., 2004). However, data on action potential
conﬁguration from isolated myocytes are not abundant, partic-
ularly with the second-messenger systems intact. In the present
study, we used the amphotericin-perforated patch-clamp tech-
nique to record action potentials from isolated rabbit SA nodal
and left atrial myocytes and assess the response to noradrena-
lin, acetylcholine, or a combination thereof, thus providing data
that may prove useful in the development of RGS protein based
therapeutical means.
MATERIALS AND METHODS
CELL PREPARATION
All experiments were carried out in accordance with guidelines of
the local institutional animal care and use committee. In addition,
the investigation complied with the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). Both SA nodal
and atrial cells were isolated from hearts of male New Zealand
White rabbits of 4 months old.
Single SAnodal cellswere enzymatically isolated from the entire
SA nodal region as described previously (Verkerk et al., 2009). Sin-
gle atrial cells were isolated by enzymatic dissociation from the
left atrium using the same protocol as described previously for the
isolation of ventricular myocytes (Den Ruijter et al., 2010), with
the adaptation that the enzymatic solution was complemented
with 6.6μg/mL protease. Small aliquots of either SA nodal or
atrial cell suspension were put in a recording chamber on the
stage of an inverted microscope. Cells were allowed to adhere for
5 min after which superfusion with Tyrode’s solution was started.
Tyrode’s solution had a temperature of 36 ± 0.2˚C and contained
(in mM): NaCl 140, KCl 5.4, CaCl2 1.8, MgCl2 1.0, glucose 5.5,
and HEPES 5.0; pH was set to 7.4 with NaOH. Spindle and
elongated spindle-like cells displaying regular contractions were
selected for recordings from SA nodal myocytes. Intrinsically qui-
escent rod-shaped cross-striated myocytes with a smooth surface
were selected for recording from atrial myocytes.
PATCH-CLAMP EXPERIMENTS
Action potentials were recorded by the amphotericin-perforated
patch-clamp technique using an Axopatch 200B ampliﬁer (Mole-
cular Devices, Sunnyvale, CA, USA). SA nodal action potentials
were low-pass ﬁltered (cut-off frequency 1 kHz) and digitized
at 2 kHz; atrial action potentials at 5 and 40 kHz, respectively.
Potentials were corrected for the estimated liquid junction poten-
tial (Barry and Lynch, 1991). Data acquisition and analysis were
accomplished using custom software. For recording fromSAnodal
myocytes, pipettes (borosilicate glass; resistance 2–3 MΩ) were
heat polished and ﬁlled with solution containing (in mM): K-
gluc 125, KCl 20, NaCl 10, amphotericin-B 0.22, and HEPES 10;
pH was set to 7.2 with KOH. For recording from atrial myocytes,
the pipette solution contained (in mM): K-gluc 110, KCl 30, NaCl
5, MgCl2 1, amphotericin-B 0.22, and HEPES 10; pH was set to
7.28 with KOH. Action potentials in atrial cells were elicited at 1–
4 Hz by 2-ms, ≈1.5× threshold current pulses through the patch
pipette.
Action potentials were characterized by duration at 20, 50,
and 90% repolarization (APD20,APD50, andAPD90, respectively),
maximum diastolic potential (MDP), action potential amplitude,
maximum upstroke velocity, and, in case of SA nodal myocytes,
cycle length and diastolic depolarization rate measured over the
50-ms time interval starting at MDP +1 mV. Parameter values
obtained from 10 consecutive action potentials were averaged.
Action potentials were measured in the absence and presence of
noradrenalin, acetylcholine, or a combination of both in the same
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myocyte. In case of atrial myocytes, the myocyte was stimulated
at a frequency of 2 Hz, unless otherwise stated. In order to obtain
steady-state conditions, action potential recordings were started
5 min after the addition of noradrenalin or acetylcholine to the
Tyrode’s solution.
STATISTICS
Data are presented as mean± SEM. Paired comparisons were
made using a paired t -test. Group comparisons were made using
either anunpaired t -test or one-wayANOVAwith theHolm–Sidak
post hoc test. Frequency dependence and dose dependence were
assessed with the Friedman repeated measures ANOVA on ranks,
followed by pairwise comparisons with the Student–Newman–
Keuls post hoc test. P < 0.05 deﬁned statistical signiﬁcance.
RESULTS
ACTION POTENTIAL CHARACTERISTICS OF SA NODAL AND ATRIAL
MYOCYTES
First, we characterized the action potentials of the SA nodal
and left atrial myocytes that we used for our study. SA nodal
cells were spontaneously active, while atrial cells were quies-
cent. In atrial cells, action potentials could be elicited by current
pulses through the patch pipette. Figure 1A shows typical spon-
taneous action potentials of an SA nodal myocyte as well as
typical action potentials recorded from an atrial myocyte that
was stimulated at 3 Hz, i.e., with a cycle length similar to that
of the SA nodal myocyte. Average action potential parameters
are summarized in Figure 1B. All parameters, except APD90, dif-
fered signiﬁcantly between both cell types. Atrial myocytes had a
stable resting membrane potential of −79.2± 1.1 mV (n = 12),
while SA nodal cells showed a spontaneous diastolic depolar-
ization with a maximum diastolic potential of −63.5± 1.7 mV
(n = 12). In SA nodal cells, this diastolic depolarization resulted in
pacemaker activity with an intrinsic cycle length of 302± 10 ms.
In SA nodal cells, the maximum upstroke velocity was typically
low (6.6± 1.1V/s) as opposed to atrial myocytes (297± 39V/s).
In both cell types, action potentials overshot the zero potential
value, but the APA was higher in atrial myocytes. Action poten-
tials of atrial myocytes repolarized earlier and faster, resulting in
shorter APD20 and APD50; however, APD90 did not differ signiﬁ-
cantly. Atrial action potentials showed a frequency dependence in
maximum upstroke velocity, APD20 and APD50. Both APD20 and
APD50 increased with an increase in stimulus frequency, whereas
maximum upstroke velocity tended to decrease with an increase
in frequency (Figure 1C).
EFFECTS OF NORADRENALIN AND ACETYLCHOLINE ON SA NODAL
ACTION POTENTIALS
Next, we assessed the effects of noradrenalin, acetylcholine, or a
combination thereof on the action potentials of our SA nodal
myocytes. As illustrated in Figure 2A, application of noradrena-
lin resulted in an increase in the spontaneous beating frequency,
associated with an increase in the diastolic depolarization rate
without any striking differences in other action potential para-
meters. Application of acetylcholine, on the other hand, resulted
in a clear hyperpolarization of the maximum diastolic poten-
tial, a decrease in the diastolic depolarization rate and a dramatic
increase in cycle length (Figure 2B). If acetylcholine was applied
FIGURE 1 | Action potential characteristics of isolated rabbit SA
nodal (SAN) and atrial myocytes. (A)Typical action potentials of an
isolated SA nodal myocyte and an atrial myocyte. The atrial myocyte was
stimulated at 3Hz. (B) Action potential parameters of SA nodal and atrial
myocytes, including maximum diastolic potential (MDP), action potential
amplitude (APA), maximum upstroke velocity (dV /dtmax), and action
potential duration at 20, 50, and 90% repolarization (APD20, APD50, and
APD90, respectively). The atrial myocytes were stimulated at 3Hz.
Asterisks indicate signiﬁcant differences between both cell types. (C)
Frequency dependence of the action potential parameters of the atrial
myocytes. Asterisks indicate signiﬁcant differences between stimulus
frequencies.
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FIGURE 2 | Effects of noradrenalin, acetylcholine, or a combination of
both on the action potentials of isolated rabbit SA nodal myocytes.
(A)Typical action potentials of an isolated SA nodal myocyte under control
conditions (“Ctrl,” black line) and in the presence of 1μM noradrenalin
(“NA,” red line). (B)Typical action potentials of an isolated SA nodal
myocyte under control conditions (“Ctrl,” black line) and in the presence of
1μM acetylcholine (“ACh,” blue line). (C)Typical action potentials of an
isolated SA nodal myocyte under control conditions (“Ctrl,” black line), in
the presence of noradrenalin (“NA,” red line), and in the presence of both
noradrenalin and acetylcholine (“NA+ACh,” green line).
in the presence of noradrenalin, there was no substantial hyper-
polarization of the maximum diastolic potential and the increase
in cycle length was less prominent (Figure 2C).
Figure 3 summarizes the effects on action potential parame-
ters for a total of 13 cells. These data conﬁrm the aforementioned
effects on cycle length (Figure 3A), diastolic depolarization rate
(Figure 3B), and maximum diastolic potential (Figure 3C). In
addition, Figure 3 shows that both noradrenalin and acetyl-
choline caused an increase in maximum upstroke velocity, which
was larger in case of acetylcholine (Figure 3E). Figure 3 may
suggest that acetylcholine increases action potential amplitude
(Figure 3D) and action potential duration (Figures 3F–H), but
it should be noted that these data are not statistically signiﬁ-
cant. According to Figure 3, and also Figure 2C, intermediate
results were obtained in the combined presence of noradrenalin
and acetylcholine, but it should be noted that these observations
are based on data from only one cell, as emphasized by the use of
“bleached” bars for “NA+ACh” in Figure 3.
EFFECTS OF NORADRENALIN AND ACETYLCHOLINE ON ATRIAL ACTION
POTENTIALS
We also assessed the effects of noradrenalin, acetylcholine, or
a combination thereof on the action potentials of our atrial
myocytes. The results are shown in Figures 4–7.
As illustrated in Figure 4A, application of noradrenalin resulted
in a slight hyperpolarization of the maximum diastolic poten-
tial. The same was found for acetylcholine (Figure 4B), but not
so much for the combination of noradrenalin and acetylcholine
(Figure 4C). In all cases, i.e., application of noradrenalin,
FIGURE 3 | Change in action potential parameters of isolated rabbit SA
nodal myocytes in response to 1μM noradrenalin (“NA,” red bars),
1μM acetylcholine (“ACh,” blue bars), or a combination of both
noradrenalin and acetylcholine (“NA+ACh,” green bars). Asterisks
indicate signiﬁcant differences between effects of noradrenalin and
acetylcholine. Hashes indicate signiﬁcant differences from control.
(A) Change in cycle length. (B) Change in diastolic depolarization rate
measured over the 50-ms time interval starting at maximum diastolic
potential +1mV (DDR50). (C) Change in maximum diastolic potential (MDP).
(D) Change in action potential amplitude (APA). (E) Change in maximum
upstroke velocity (dV /dtmax). (F) Change in action potential duration at 20%
repolarization (APD20). (G) Change in action potential duration at 50%
repolarization (APD50). (H) Change in action potential duration at 90%
repolarization (APD90).
acetylcholine, or a combination thereof, the action potential
amplitude was increased. Effects on action potential dura-
tion differed between noradrenalin and acetylcholine, with an
increase in case of noradrenalin and a decrease for acetylcholine
(Figures 4A,B) and a less pronounced effect for the combination
of noradrenalin and acetylcholine (Figure 4C).
Figure 5 summarizes the effects on action potential parameters
for a total of 23 cells. As already observed in the typical examples
of Figure 4, there is a slight hyperpolarization of the maximum
diastolic potential (Figure 5A) and an increase in action poten-
tial amplitude (Figure 5B). Also, under all conditions there is an
increase in maximum upstroke velocity (Figure 5C). The effects
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FIGURE 4 | Effects of noradrenalin, acetylcholine, or a combination of
both on the action potentials of isolated rabbit left atrial myocytes.
(A)Typical action potentials of an isolated atrial myocyte under control
conditions (“Ctrl,” black line) and in the presence of 1μM noradrenalin
(“NA,” red line). (B)Typical action potentials of an isolated atrial myocyte
under control conditions (“Ctrl,” black line) and in the presence of 1μM
acetylcholine (“ACh,” blue line). (C)Typical action potentials of an atrial
myocyte under control conditions (“Ctrl,” black line) and in the presence of
both noradrenalin and acetylcholine (“NA+ACh,” green line).
on APD50 and APD90 are different between the three conditions,
with a decrease in case of acetylcholine, an increase in case of
noradrenalin and a smaller, but still signiﬁcant increase in case of
acetylcholine combined with noradrenalin (Figures 5E,F).
In addition to the experiments of Figures 4 and 5, in which the
cells were stimulated at 2 Hz, we carried out experiments in which
we varied the stimulation frequency over the range of 1–4 Hz. The
data, obtained from a total of 12 cells, did not reveal a clear-cut
frequency dependence in the effects of acetylcholine or noradren-
alin on action potential duration (Figure 6). Data obtained in the
combined presence of noradrenalin and acetylcholine are from
only two cells and therefore appear “grayed out” in Figure 6.
The above data were obtained with noradrenalin and acetyl-
choline concentrations of 1μM (1000 nM). In a total of ﬁve cells,
we varied these concentrations over the range of 1–1000 nM. The
effects on action potential duration showed a dose dependence,
in particular for APD50, with considerably smaller effects at 1 nM
than at 1μM (Figure 7). However, it should be noted that the
data with acetylcholine are from one cell, as are the data in the
combined presence of noradrenalin and acetylcholine. These data
therefore appear “grayed out” in Figure 7.
DISCUSSION
In the present study, we have assessed the effects of noradrenalin,
acetylcholine, or a combination thereof on the action potential
conﬁguration of rabbit SA nodal and left atrial myocytes. Action
potentials were recorded under close-to-physiological conditions.
FIGURE 5 | Change in action potential parameters of isolated rabbit
left atrial myocytes in response to 1μM noradrenalin (“NA,” red bars),
1μM acetylcholine (“ACh,” blue bars), or a combination of both
noradrenalin and acetylcholine (“NA+ACh,” green bars). Asterisks
indicate signiﬁcant differences between effects of noradrenalin,
acetylcholine, or a combination of both. Hashes indicate signiﬁcant
differences from control. (A) Change in maximum diastolic potential (MDP).
(B) Change in action potential amplitude (APA). (C) Change in maximum
upstroke velocity (dV /dtmax). (D) Change in action potential duration at 20%
repolarization (APD20). (E) Change in action potential duration at 50%
repolarization (APD50). (F) Change in action potential duration at 90%
repolarization (APD90).
The temperature of the bath solution was maintained at 36˚C
and the amphotericin-perforated patch-clamp technique was used
to minimize intracellular dialysis, thus maintaining the integrity
of second-messenger systems. To the best of our knowledge, the
present study is the ﬁrst in which the effects of noradrenalin,
acetylcholine, or a combination thereof on the action potential
conﬁguration of isolated sinoatrial and atrial myocytes has been
tested in detail under such close-to-physiological conditions.
As detailed in Figure 1, our SA nodal and atrial myocytes
showed clearly distinct action potential characteristics. We
obtained our myocytes from rabbit, which is a widely used animal
model in the ﬁeld of cardiac cellular electrophysiology. In many
respects, human action potential morphology is better resembled
by rabbit than by mouse (Brunner et al., 2008). Yet, one should
be aware that there may be species differences in the underlying
mechanisms, as there are, e.g., in calcium handling and adenylate
cyclase activity between mouse and man (Jweied et al., 2007).
EFFECTS OF NORADRENALIN AND ACETYLCHOLINE ON SA NODAL
ACTION POTENTIALS
The beating rate of our SA nodal cells increases upon application
of noradrenalin and decreases upon application of acetylcholine
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FIGURE 6 | Frequency dependence of the changes in action potential
duration of isolated rabbit left atrial myocytes in response to 1μM
noradrenalin (“NA,” red symbols), 1μM acetylcholine (“ACh,” blue
symbols), or a combination of both noradrenalin and acetylcholine
(“NA+ACh,” green symbols). Cells were stimulated at 1–4Hz. Asterisk
indicates signiﬁcant difference between stimulus frequencies. (A) Action
potential duration at 50% repolarization (APD50). (B) Action potential duration
at 90% repolarization (APD90).
FIGURE 7 | Dose dependence of the changes in action potential
duration of isolated rabbit left atrial myocytes in response to
noradrenalin (“NA,” red symbols), acetylcholine (“ACh,” blue
symbols), or a combination of both (“NA+ACh,” green symbols).
Concentration was varied between 1 and 1000nM. Asterisks indicate
signiﬁcant differences between concentrations. (A) Action potential
duration at 50% repolarization (APD50). (B) Action potential duration at
90% repolarization (APD90). Note logarithmic abscissa.
(Figures 2A,B and 3A), which is associated with an increase and
a decrease in the rate of diastolic depolarization, respectively
(Figure 3B). It is tempting to explain this change in depolar-
ization rate by a cAMP-mediated upregulation or downregula-
tion of the hyperpolarization-activated “pacemaker current” or
“funny current” I f (DiFrancesco, 1995). However, one should be
cautious when drawing conclusions regarding underlying mech-
anisms from changes in action potentials. This may be illustrated
by the increase in maximum upstroke velocity that is observed
in response to noradrenalin as well as acetylcholine (Figure 3E).
In case of noradrenalin, this increase may well result from an
upregulation of the L-type calcium current ICa,L (Hagiwara et al.,
1988), but in case of acetylcholine the even larger increase may
be the effect of less voltage-dependent inactivation of ICa,L due
to the larger recovery time between consecutive upstrokes and
less calcium-dependent inactivation of ICa,L due to the smaller
calcium transients (van Borren et al., 2010). Additionally, the acti-
vation of a small number of fast sodium channels may have con-
tributed to the increase in maximum upstroke velocity as a result
of the acetylcholine-induced hyperpolarization of the maximum
diastolic potential which results in incomplete voltage-dependent
inactivation of these channels (Veldkamp et al., 2003).A full explo-
ration of the autonomic modulation of the complex dynamic
interactions of voltage- and calcium-dependent processes within
the SA nodal pacemaker cell may require in silico experiments
(Maltsev and Lakatta, 2010). Such experiments have already
proven useful in a computer simulation study of the autonomic
modulation of the electrical activity of bullfrog atrial myocytes
(Shumaker et al., 1991). Figures 3F–H suggest an increase in
action potential duration in response to acetylcholine, but this
may reﬂect, at least in part, the hyperpolarization of the maxi-
mum diastolic potential (Figure 3C) rather than a “true” increase
in action potential duration. This hyperpolarization can be readily
explained by the activation of IK,ACh (van Borren et al., 2010).
A reduction in beating frequency as well as a hyperpolarization
of the maximum diastolic potential was also reported for SA nodal
myocytes isolated from wild-type mice in response to carbachol
(Cifelli et al., 2008). These effects were both larger for myocytes
fromRGS4−/− mice. In the top panel of theirOnline Figure 5,Yang
et al. (2010) show“representative recordings of spontaneous action
potential ﬁring in SA nodal myocytes isolated from wild-type
mice.” With an increase in cycle length, a decrease in diastolic
Frontiers in Physiology | Cardiac Electrophysiology May 2012 | Volume 3 | Article 174 | 6
Verkerk et al. Effects of acetylcholine and noradrenalin
depolarization rate, a hyperpolarization of the maximum dias-
tolic potential and an increase in action potential amplitude, the
changes in action potential conﬁguration in response to carba-
chol are consistent with our data for rabbit SA nodal myocytes in
response to acetylcholine (Figure 3).
EFFECTS OF NORADRENALIN AND ACETYLCHOLINE ON ATRIAL ACTION
POTENTIALS
In our atrial myocytes, we found a hyperpolarization of the max-
imum diastolic potential (or “resting” membrane potential) in
response to acetylcholine (Figure 5A), as we did in our SA nodal
myocytes (Figure 3C). However, in contrast to our SA nodal
myocytes, such hyperpolarization was also observed in response
to noradrenalin. This may be explained by the β-adrenergic acti-
vation of IK,ACh in atrial myocytes (Sorota et al., 1999) and by
the β-adrenergic stimulation of the atrial-speciﬁc potassium cur-
rent IKH (Ehrlich et al., 2004; Yeh et al., 2007). Furthermore, we
found an increase in action potential amplitude and, as in our
SA nodal myocytes, an increase in maximum upstroke velocity
both in response to noradrenalin and in response to acetylcholine
(Figures 5B,C). This may be explained by an increase in the
fast sodium current, which is responsible for the fast upstroke in
atrial cells, due to the more negative maximum diastolic potential
and thus larger availability of fast sodium channels (less voltage-
dependent inactivation). On the other hand, increased intracellu-
lar calcium levels in response to noradrenalin may have inhibitory
effects on these sodium channels (Casini et al., 2009), but such
effects are not apparent in our current data.
Action potential duration is increased in response to noradren-
alin and decreased in response to acetylcholine, with more or less
additive effects if both noradrenalin and acetylcholine are present
(Figures 5D–F). The shortening of the action potential in response
to acetylcholine is in line with data from literature (Koumi et al.,
1995; Patterson et al., 2008) andmay be attributed to the activation
of IK,ACh. Of note, acetylcholine does not inhibit the L-type cal-
cium current of atrialmyocytes under basal conditions, in contrast
to that of SA nodal myocytes (Petit-Jacques et al., 1993).
The increase in action potential duration in response to nora-
drenalin (Figures 5D–F) may be attributed to the increase in
ICa,L in response to β-adrenergic stimulation (Bean, 1985; Dun
et al., 2003), which would then be sufﬁciently large to counter-
act the action potential shortening effects of the aforementioned
β-adrenergic activation of IK,ACh and IKH. However, Yeh et al.
(2007) observed a prominent decrease in action potential dura-
tion in a canine left atrial tissue preparation in response to speciﬁc
β-adrenergic stimulation by isoproterenol (isoprenaline, 5 μM).
This suggests that theα-adrenergic action of noradrenalin is essen-
tial for the increase in action potential duration that we observed
in our experiments. A clear increase in action potential duration in
response to the selective α1-adrenergic receptor agonist phenyle-
phrine (100μM) has been observed in left, but not right, atrial
preparations from rabbit heart (Jahnel et al., 1992). In isolated
rat atria, Northover (1994) also observed a signiﬁcant increase in
action potential duration in response to phenylephrine (50 μM),
whereas the effects of isoproterenol (0.5 μM) were small and
rather variable. In contrast, phenylephrine (100μM) only had
a minor effect on action potential duration in the experiments
by Yeh et al. (2007). The apparent discrepancies in experimental
results may be explained by species- and tissue-dependent dif-
ferences and/or by differences in cAMP levels due to differences
in basal adenylyl cyclase activity (Méry et al., 1997; Harvey and
Belevych, 2003). Furthermore, a dose dependence in the effects of
isoproterenol and phenylephrine on the action potential and the
underlying transmembrane currents may play a role (Shumaker
et al., 1991).
The data on actionpotential duration of Figure 5were obtained
at a stimulus frequency of 2 Hz. Figure 6 demonstrates that similar
effects were obtained at other frequencies in the range of 1–4 Hz,
without a clear-cut frequency dependence, although the increase
in APD50 at 1 Hz in the presence of noradrenalin is signiﬁcantly
different from that at 4 Hz. The data at 2 Hz of Figure 6A are in
line with the data of Figure 5E. Also, there is consistency between
the data at 2 Hz of Figure 6B and the data of Figure 5F. How-
ever, the difference between “NA” and “NA +ACh” in Figure 6B
is smaller than expected from Figure 5F, where this difference is
almost signiﬁcant (P = 0.06).
CAVEATS
In the present study, we have used the amphotericin-perforated
patch-clamp technique to test the effects of noradrenalin, acetyl-
choline, or a combination thereof on the action potential conﬁg-
uration of isolated sinoatrial and atrial myocytes under close-to-
physiological conditions. Whereas this approach allows a detailed
study of the effects of a well-controlled dose of these neurotrans-
mitters on the intrinsic action potential conﬁguration of these
isolated myocytes, it does not take into account the complexity
and heterogeneity of the intact myocardium. Therefore, caution
should be applied when translating our in vitro results to the
in vivo situation. Furthermore, although human action poten-
tial morphology is better resembled by rabbit than by mouse,
there may be species differences in the effects of noradrenalin and
acetylcholine.
CONCLUSION
Our data show that acetylcholine and noradrenalin can modulate
the beating rate of SA nodal myocytes and the action potential
duration of atrial myocytes over a wide range. If speciﬁc SA nodal
RGS protein isoforms exist that suppress muscarinic or adrenergic
sensitivity of the SA node, they may prove therapeutical targets
for the treatment of SA nodal bradycardia or tachycardia. Atrial-
speciﬁc RGS protein isoforms may prove useful as therapeutical
targets to increase the adrenergic sensitivity of atrial cells, thereby
increasing their action potential duration and refractory period
and thus decreasing the risk of atrial tachycardia and ﬁbrillation.
This will, however, require a large body of research before one can
think of clinical translation.
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